# FDA Warning Letter: Pharmathen International S.A.
> 2026-06-16 · Center for Drug Evaluation and Research (CDER) · `4e8a15d66524fbeb`
## Letter
- **Company:** Pharmathen International S.A.
- **Posted Date:** 2026-06-16
- **Letter Issue Date:** 2026-05-27
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · MORVS · CC0 1.0*